alpha-Glucosidase-IN-110 is a selective and orally active competitive inhibitor of alpha-Glucosidase with an IC50 of 7.09 µM and a Ki of 6.9 µM. alpha-Glucosidase-IN-110 can reduce fasting blood glucose levels, improve glucose tolerance, and restore the histomorphology of liver and pancreatic tissues in diabetic rat models. alpha-Glucosidase-IN-110 can be used for the research of diabetes[1].
Molecular Weight:
517.00
Formula:
C26H21ClN6O2S
Target:
Glycosidase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
